Literature DB >> 3658067

Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis.

A N Murray1, M J Cassidy, C Templecamp.   

Abstract

Two months after commencing continuous treatment with rifampicin, isoniazid, streptomycin and pyrazinamide for pulmonary tuberculosis a patient developed a nephrotic syndrome, acute nonoliguric renal failure and evidence of intravascular hemolysis. Renal biopsy revealed a severe crescentic nephritis with mild interstitial changes. The use of rifampicin has been associated with various renal abnormalities and this report documents the occurrence of a rapidly progressive crescentic glomerulonephritis presenting as nephrotic syndrome in a patient receiving continuous treatment with rifampicin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3658067     DOI: 10.1159/000184394

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Crescentic Glomerulonephritis Associated with Pulmonary Tuberculosis.

Authors:  K V Kanodia; A V Vanikar; R D Patel; K S Suthar; H L Trivedi
Journal:  J Clin Diagn Res       Date:  2016-01-01

2.  Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy.

Authors:  Dong Hyuk Park; Sul A Lee; Hyeon Joo Jeong; Tae-Hyun Yoo; Shin-Wook Kang; Hyung Jung Oh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.